Flow Cytometry, Ektacytometry, DNA Ploidy, and S-phase Fraction
Customize your policy alerts
Sign up for Aetna Policy 0351 alerts
Get alerted when Policy 0351 changes without checking for updates manually.
Monitor payer policy activity
Clinical coverage and medical necessity policy for use of flow cytometry (cell surface markers, DNA ploidy, S‑phase fraction) and ektacytometry, including indications considered medically necessary, investigational/experimental exclusions, and coding guidance affecting ordering clinicians and laboratories.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.